| 000 | 01798 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517015435.0 | ||
| 264 | 0 | _c20150320 | |
| 008 | 201503s 0 0 eng d | ||
| 022 | _a1784-3227 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBourgeois, S | |
| 245 | 0 | 0 |
_aA non-interventional phase IV Belgian survey to assess the antiviral effectiveness of pegylated interferon-alpha-2b and ribavirin treatment according to the stage of liver fibrosis in previously untreated patients with genotype 1/4/5/6 chronic hepatitis C (PRACTICE). _h[electronic resource] |
| 260 |
_bActa gastro-enterologica Belgica _cDec 2014 |
||
| 300 |
_a393-400 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase IV; Journal Article; Multicenter Study; Observational Study | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntiviral Agents _xadministration & dosage |
| 650 | 0 | 4 | _aData Collection |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHepacivirus _xgenetics |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterferon alpha-2 |
| 650 | 0 | 4 |
_aInterferon-alpha _xadministration & dosage |
| 650 | 0 | 4 |
_aLiver Cirrhosis _xpathology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPolyethylene Glycols _xadministration & dosage |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
| 650 | 0 | 4 |
_aRibavirin _xadministration & dosage |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aDeltenre, P | |
| 700 | 1 | _aDelwaide, J | |
| 700 | 1 | _aHenrion, J | |
| 700 | 1 | _aAdler, M | |
| 700 | 1 | _aLanglet, Ph | |
| 700 | 1 | _aMulkay, J-P | |
| 700 | 1 | _aNevens, F | |
| 700 | 1 | _aBrixko, C | |
| 700 | 1 | _aMoreno, C | |
| 773 | 0 |
_tActa gastro-enterologica Belgica _gvol. 77 _gno. 4 _gp. 393-400 |
|
| 999 |
_c24624310 _d24624310 |
||